Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kellner, Christian  [Clear All Filters]
2024
Schewe DM, Vogiatzi F, Münnich IA, Zeller T, Windisch R, Wichmann C, Müller K, Bhat H, Felix E, Mougiakakos D, et al. Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade. Hemasphere. 2024;8(2):e48.
2022
Müller K, Vogiatzi F, Winterberg D, Rosner T, Lenk L, Bastian L, Gehlert CL, Autenrieb MPauline, Brüggemann M, Cario G, et al. Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL. Blood. 2022.
2021
Baumann N, Rosner T, Jansen JHMarco, Chan C, Eichholz KMarie, Klausz K, Winterberg D, Müller K, Humpe A, Burger R, et al. Enhancement of EGFR antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/SIRPα interactions. Cancer Sci. 2021.
Kellner C, Lutz S, Oberg H-H, Wesch D, Otte A, Diemer KJ, Wilcken H, Bauerschlag D, Glüer C-C, Wichmann C, et al. Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen. Biol Chem. 2021.
2018
Kellner C, Derer S, Klausz K, Rosskopf S, Wirt T, Rosner T, Otte A, Cappuzzello E, Peipp M. Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC Activity. Methods Mol Biol. 2018;1827:381-397.
2015
Derer S, Cossham M, Rosner T, Kellner C, Beurskens FJ, Schwanbeck R, Lohse S, Sina C, Peipp M, Valerius T. A Complement-Optimized EGFR Antibody Improves Cytotoxic Functions of Polymorphonuclear Cells against Tumor Cells. J Immunol. 2015.
Guenther A, Baumann P, Burger R, Kellner C, Klapper W, Schmidmaier R, Gramatzki M. Everolimus (RAD001) Activity in Relapsed and/or Refractory Multiple Myeloma: A Phase I Study. Haematologica. 2015.
Oberg H-H, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, Kabelitz D, Wesch D. γδ T cell activation by bispecific antibodies. Cell Immunol. 2015.
2014
Oberg H-H, Kellner C, Peipp M, Sebens S, Adam-Klages S, Gramatzki M, Kabelitz D, Wesch D. Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy. Front Immunol. 2014;5:643.